Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-04-22

Clinical Trial Update: Hybrid AF -- A Prospective Registry

View source ↗

Summary

The Hybrid AF prospective registry for atrial fibrillation has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Dhanunjaya Lakkireddy, MD, FACC | Conditions: Atrial Fibrillation | Status: WITHDRAWN